» Articles » PMID: 30774839

Cerium Oxide Nanoparticles Protect Cyclophosphamide-induced Testicular Toxicity in Mice

Overview
Journal Int J Prev Med
Date 2019 Feb 19
PMID 30774839
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cyclophosphamide (CP), as a chemotherapy drug, causes severe damage in testicular tissue through producing free radicals. Cerium oxide nanoparticles (NC) exhibit antioxidant and anti-inflammatory properties. The purpose of this study was to investigate the protective effect of NC on CP-induced testicular damage in mice.

Methods: In this experimental study, thirty-two male mice were divided into four groups (eight mice in each group). The control group was received intraperitoneally (IP) normal saline, NC group was received NC for three consecutive days (100 μg/kg, IP), CP group was received CP (200 mg/kg, IP), and the CP + NC group received NC, three consecutive days before receiving CP. After 2 days, testicles were assessed for biochemical, histomorphometrical, histopathological, and immunohistochemical analyses.

Results: CP administration caused statistically significant increases in sperm abnormality, malondialdehyde, protein carbonyl levels, reactive oxygen species, level and apoptosis, and decreases in sperm count, sperm viability, testosterone, glutathione activity, the mean thickness of the germinal epithelium, diameter of seminiferous tubules in mice. Degeneration, necrosis, arrest of spermatogenesis, congestion, and atrophy in testicular tissue confirmed the low Johnsen's Testicular score in CP group. Administration of NC significantly ameliorated the CP-induced adverse effects on testis compared with the CP group. In addition, pretreatment mice with NC significantly reduced caspase-3 immunoreactivity induced by CP in testis.

Conclusions: This study showed that NC with scavenging free radicals and antiapoptotic properties enable to reduce the side effects of CP in the testicular tissue.

Citing Articles

The protection afforded by kefir against cyclophosphamide induced testicular toxicity in rats by oxidant antioxidant and histopathological evaluations.

Yildiz S, Demir C, Cengiz M, Irmak H, Peker Cengiz B, Ayhanci A Sci Rep. 2024; 14(1):18463.

PMID: 39122852 PMC: 11316007. DOI: 10.1038/s41598-024-67982-y.


Alkylating agents-induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front.

Sriram S, Macedo T, Mavinkurve-Groothuis A, van de Wetering M, Looijenga L Clin Transl Sci. 2024; 17(7):e13866.

PMID: 38965809 PMC: 11224131. DOI: 10.1111/cts.13866.


Preventive effects of quercetin against inflammation and apoptosis in cyclophosphamide-induced testicular damage.

Uzun-Goren D, Uz Y Iran J Basic Med Sci. 2024; 27(5):647-656.

PMID: 38629094 PMC: 11017851. DOI: 10.22038/IJBMS.2024.74458.16177.


Radioprotective Potency of Nanoceria.

Alvandi M, Shaghaghi Z, Farzipour S, Marzhoseyni Z Curr Radiopharm. 2023; 17(2):138-147.

PMID: 37990425 DOI: 10.2174/0118744710267281231104170435.


Hesperidin Mitigates Cyclophosphamide-Induced Testicular Dysfunction via Altering the Hypothalamic Pituitary Gonadal Axis and Testicular Steroidogenesis, Inflammation, and Apoptosis in Male Rats.

Khamis T, Awad Hegazy A, El-Fatah S, Abdelfattah E, Abdelfattah M, Fericean L Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259444 PMC: 9966503. DOI: 10.3390/ph16020301.


References
1.
Howell S, Radford J, Ryder W, Shalet S . Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol. 1999; 17(5):1493-8. DOI: 10.1200/JCO.1999.17.5.1493. View

2.
Ghosh D, Das U, Ghosh S, Mallick M, Debnath J . Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress. Drug Chem Toxicol. 2002; 25(3):281-92. DOI: 10.1081/dct-120005891. View

3.
Skorodumova N, Simak S, Lundqvist B, Abrikosov I, Johansson B . Quantum origin of the oxygen storage capability of ceria. Phys Rev Lett. 2002; 89(16):166601. DOI: 10.1103/PhysRevLett.89.166601. View

4.
Arenas M, Lobo M, Caso E, Huerta L, Paniagua R, Martin-Hidalgo M . Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36. Hum Pathol. 2004; 35(1):34-42. DOI: 10.1016/j.humpath.2003.08.015. View

5.
LEAR L, Nation R, Stupans I . Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem Pharmacol. 1992; 44(4):747-53. DOI: 10.1016/0006-2952(92)90412-c. View